CORRESP 1 filename1.htm

 

INVO BIOSCIENCE, INC.

5582 BROADCAST COURT

Sarasota, florida 32240

 

August 2, 2023

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

  Re: INVO Bioscience, Inc.
    Registration Statement on Form S-1
    File No. 333-273174

 

Ladies and Gentlemen:

 

INVO Bioscience, Inc. (the “Company”) hereby requests, pursuant to Rule 461 under the Securities Act of 1933, as amended, that the above-referenced registration statement be accelerated to 5:30 p.m., Eastern Time, on Thursday August 3, 2023, or as soon thereafter as practicable.

 

Very truly yours,  
   
INVO BIOSCIENCE, INC.  
   
By: /s/ Steven Shum  
Steven Shum  
Chief Executive Officer